12/14/2012

Metformin-treated patients with diabetes showed a lower risk of intrahepatic cholangiocarcinoma compared with diabetes patients not taking the drug, researchers reported in Hepatology. Biliary tract disease, cirrhosis, diabetes and smoking were associated with an increased risk of ICC onset, researchers noted.

Related Summaries